日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cost-Effectiveness of Vibrant System vs. Linaclotide in Chronic Idiopathic Constipation

Vibrant System 与利那洛肽治疗慢性特发性便秘的成本效益比较

Voigt, Jeffrey D; Frissora, Christine L

One-Stop Colon and Endometrial Screening (ONCE): a prospective study of combined cancer screening for Lynch syndrome

一站式结肠癌和子宫内膜癌筛查(ONCE):一项针对林奇综合征的联合癌症筛查前瞻性研究

Frissora, Christine L; Miller, Emily A; Matos, Thalia; Betesh, Andrea; Lipkin, Steven; Frey, Melissa K; Schnoll-Sussman, Felice

PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia

PP2A 是一种可通过 c-Myc/p21 轴决定人类和鼠类急性髓系白血病细胞命运的治疗靶向驱动因子

Swagata Goswami, Rajeswaran Mani, Jessica Nunes, Chi-Ling Chiang, Kevan Zapolnik, Eileen Hu, Frank Frissora, Xiaokui Mo, Logan A Walker, Pearlly Yan, Ralf Bundschuh, Larry Beaver, Raymond Devine, Yo-Ting Tsai, Ann Ventura, Zhiliang Xie, Min Chen, Rosa Lapalombella, Alison Walker, Alice Mims, Karilyn

The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia

ROR1抗体药物偶联物huXBR1-402-G5-PNU可有效靶向ROR1阳性白血病

Eileen Y Hu ,Priscilla Do ,Swagata Goswami ,Jessica Nunes ,Chi-Ling Chiang ,Sara Elgamal ,Ann M Ventura ,Carolyn Cheney ,Kevan Zapolnik ,Erich Williams ,Rajeswaran Mani ,Frank Frissora ,Xiaokui Mo ,Lorenz Waldmeier ,Roger R Beerli ,Haiyong Peng ,Christoph Rader ,Meixiao Long ,Ulf Grawunder ,John C Byrd ,Natarajan Muthusamy

ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model

在慢性淋巴细胞白血病(CLL)小鼠模型中,靶向ROR1递送miR-29b可诱导细胞周期阻滞并产生体内治疗效果。

Chiang, Chi-Ling; Goswami, Swagata; Frissora, Frank W; Xie, Zhiliang; Yan, Pearlly S; Bundschuh, Ralf; Walker, Logan A; Huang, Xiaomeng; Mani, Rajeswaran; Mo, Xiaokui M; Baskar, Sivasubramanian; Rader, Christoph; Phelps, Mitch A; Marcucci, Guido; Byrd, John C; Lee, L James; Muthusamy, Natarajan

Par-4 overexpression impedes leukemogenesis in the Eµ-TCL1 leukemia model through downregulation of NF-κB signaling

Par-4 过表达通过下调 NF-κB 信号传导阻碍 Eµ-TCL1 白血病模型中的白血病形成

J T Greene, Rajeswaran Mani, Rahul Ramaswamy, Frank Frissora, Max Yano, Kevan Zapolnik, Bonnie Harrington, Ronni Wasmuth, Minh Tran, Xiaokui Mo, Mary McKenna, Vivek M Rangnekar, John C Byrd, Subbarao Bondada, Natarajan Muthusamy

The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model

CD37 靶向抗体-药物偶联物 IMGN529 对人类 CLL 和新型 CD37 转基因鼠白血病模型具有高度活性

K A Beckwith, F W Frissora, M R Stefanovski, W H Towns, C Cheney, X Mo, J Deckert, C M Croce, J M Flynn, L A Andritsos, J A Jones, K J Maddocks, G Lozanski, J C Byrd, N Muthusamy

Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes

伊布替尼是 ITK 的不可逆分子抑制剂,可驱动 T 淋巴细胞中的 Th1 选择性压力

Jason A Dubovsky, Kyle A Beckwith, Gayathri Natarajan, Jennifer A Woyach, Samantha Jaglowski, Yiming Zhong, Joshua D Hessler, Ta-Ming Liu, Betty Y Chang, Karilyn M Larkin, Matthew R Stefanovski, Danielle L Chappell, Frank W Frissora, Lisa L Smith, Kelly A Smucker, Joseph M Flynn, Jeffrey A Jones, Le

OSU-DY7, a novel D-tyrosinol derivative, mediates cytotoxicity in chronic lymphocytic leukaemia and Burkitt lymphoma through p38 mitogen-activated protein kinase pathway

OSU-DY7 是一种新型 D-酪氨醇衍生物,通过 p38 丝裂原活化蛋白激酶通路介导慢性淋巴细胞白血病和伯基特淋巴瘤的细胞毒性

Li-Yuan Bai, Yihui Ma, Samuel K Kulp, Shu-Huei Wang, Chang-Fang Chiu, Frank Frissora, Rajeswaran Mani, Xiaokui Mo, David Jarjoura, John C Byrd, Ching-Shih Chen, Natarajan Muthusamy

FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma

FTY720 显示出对慢性淋巴细胞白血病和淋巴细胞白血病/淋巴瘤有希望的临床前活性

Qing Liu, Xiaobin Zhao, Frank Frissora, Yihui Ma, Ramasamy Santhanam, David Jarjoura, Amy Lehman, Danilo Perrotti, Ching-Shih Chen, James T Dalton, Natarajan Muthusamy, John C Byrd